Jennifer Haw Ling Lai, MD
Gastroenterology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Alameda Health System · 597 clinicians in this group
Hospitals listed: Alameda Hospital · Highland Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lai’s office at (510) 437-4800 to ask if they take your plan before you enroll.
California Medical Board record
Licence A119776 · Current
Licensed to practise in California · since 2012 · expires 2027-08-31 · New York Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alameda HospitalAlameda, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Alameda Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 119 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,359 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.6 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
What patients said (319 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$22,704
Medicare paid this office $22,704 for 119 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,316 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,868 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,248 | $191 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,470 | $98 |
| Biopsy of large bowel using a flexible endoscope | 11 | $836 | $76 |
See all 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,316 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $5,868 | $107 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 17 | $3,248 | $191 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,470 | $98 |
| Biopsy of large bowel using a flexible endoscope | 11 | $836 | $76 |
| Measurement of liver stiffness | 27 | $200 | $7 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $48 | $4 |
Procedures Medicare counted
| Colonoscopy | 68 | More than 70% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 36 | More than 59% of doctors who do this |
Who their Medicare patients are
119 Original Medicare patients in 2024. Average age 70 · Women 55% · Health risk score 1.80. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 45% · Chronic kidney disease 34% · Heart failure 25% · Atrial fibrillation 25% · COPD 24% · Depression 23% · Coronary heart disease 22% · Stroke 16% · Dementia 15% · Cancer 13%.
The office billed $130,217, Medicare allowed $29,480 and paid $22,704; for 219 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 119 | 219 | 70 | 1.80 | $130,217 | $22,704 |
| 2023 | 76 | 134 | 69 | 1.93 | $65,522 | $11,698 |
| 2022 | 79 | 128 | 69 | 1.81 | $90,269 | $11,425 |
| 2021 | 168 | 325 | 70 | 1.70 | $226,456 | $30,899 |
| 2020 | 148 | 296 | 70 | 1.52 | $175,045 | $25,612 |
| 2019 | 151 | 335 | 72 | 1.19 | $341,982 | $37,830 |
| 2018 | 80 | 132 | 72 | 1.22 | $146,668 | $16,115 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 13 | $2,849 | $219 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,045 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,507 | $72 |
| Measurement of liver stiffness | 17 | $155 | $9 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $94 | $4 |
2022: 5 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,316 | $165 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,257 | $205 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,746 | $92 |
| Measurement of liver stiffness | 15 | $87 | $6 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $61 | $4 |
2021: 12 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,764 | $180 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $4,461 | $223 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,106 | $93 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,307 | $92 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,043 | $146 |
| Biopsy of large bowel using a flexible endoscope | 17 | $1,769 | $104 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $1,729 | $79 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,072 | $89 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $689 | $41 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 17 | $480 | $28 |
| Short return visit | 11 | $295 | $27 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $180 | $11 |
2020: 8 services
| Return visit (30+ min) | 43 | $4,217 | $75 |
| New patient visit (60+ min) | 25 | $3,747 | $150 |
| Long return visit (40+ min) | 17 | $2,333 | $123 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,049 | $186 |
| New patient visit (45+ min) | 14 | $1,609 | $115 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,238 | $73 |
| Telehealth originating site facility fee | 38 | $988 | $21 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $49 | $4 |
2019: 8 services
| Return visit (30+ min) | 49 | $7,945 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,158 | $212 |
| New patient visit (45+ min) | 47 | $5,918 | $126 |
| New patient visit (60+ min) | 32 | $5,737 | $179 |
| Long return visit (40+ min) | 22 | $2,951 | $128 |
| Biopsy of large bowel using a flexible endoscope | 34 | $2,896 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,286 | $86 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 21 | $86 | $4 |
2018: 5 services
| New patient visit (45+ min) | 30 | $4,478 | $149 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,404 | $219 |
| New patient visit (30+ min) | 16 | $1,421 | $89 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,204 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,092 | $99 |
Medicaid work
$44,468 in 2024
Medicaid paid $44,468 for 618 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 141 | $19,143 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 60 | $12,308 |
| Upper gastrointestinal endoscopy with biopsy | 42 | $3,157 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 77 | $2,709 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 23 | $2,010 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 12 | $1,479 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 125 | $1,265 |
| TISSUE EXAM BY PATHOLOGIST | 51 | $1,148 |
| Injection, propofol, 10 mg | 13 | $638 |
| Injection, midazolam hydrochloride, per 1 mg | 14 | $349 |
| Fentanyl citrate injection | 29 | $263 |
| Long return visit (40+ min) | 31 | $0 |
| 2024 | 618 | 12 | 28 | $44,468 |
| 2023 | 335 | 8 | 18 | $27,704 |
| 2022 | 159 | 6 | 20 | $8,427 |
| 2021 | 24 | 1 | 12 | $494 |
| 2020 | 12 | 1 | 12 | $1,088 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 63 | $11,177 |
| Clinic visit/encounter, all-inclusive | 61 | $8,000 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 75 | $3,534 |
| Upper gastrointestinal endoscopy with biopsy | 27 | $2,611 |
| TISSUE EXAM BY PATHOLOGIST | 28 | $1,008 |
| Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time | 24 | $812 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 28 | $317 |
| Fentanyl citrate injection | 29 | $244 |
2022
| Clinic visit/encounter, all-inclusive | 36 | $4,577 |
| Upper gastrointestinal endoscopy with biopsy | 26 | $1,795 |
| TISSUE EXAM BY PATHOLOGIST | 31 | $1,079 |
| Injection, propofol, 10 mg | 12 | $485 |
| Liver elastography, mechanically induced shear wave (eg, vibration), without imaging, with interpretation and report | 24 | $262 |
| Fentanyl citrate injection | 30 | $229 |
2021
| TISSUE EXAM BY PATHOLOGIST | 24 | $494 |
2020
| Moderate sedation services provided by a physician or other qualified health care professional other than the physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $1,088 |
Drugs they prescribed that Part D paid
$9,660
Pharmacies billed $9,660 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 59) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
49 generic and fewer than 11 brand-name prescriptions · $9,660 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Omeprazole | 11 | $131 | $12 |
Year by year
| 2024 | 59 | 32 | 0% (0) | None | $9,660 |
| 2023 | 53 | 45 | 0% (0) | 26% | $7,622 |
| 2022 | 83 | 48 | 0% (0) | 54% | $29,454 |
| 2021 | 76 | 50 | 0% (0) | 59% | $84,173 |
| 2020 | 171 | 69 | 0% (0) | 23% | $31,435 |
| 2019 | 288 | 126 | 0% (0) | 36% | $40,805 |
| 2018 | 112 | 72 | 0% (0) | 49% | $8,174 |
| 2017 | 11 | None | 0% (0) | None | $36,729 |
| 2015 | 19 | None | None | 89% | $40,201 |
| 2013 | 43 | 16 | None | None | $3,333 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gavilyte-G | 24 | $432 | $18 |
2022: 3 drugs
| Vemlidy | 12 | $18,789 | $1,566 |
| Golytely | 13 | $183 | $14 |
| Peg-3350 and Electrolytes | 12 | $157 | $13 |
2021: 3 drugs
| Vemlidy | 12 | $15,484 | $1,290 |
| Peg-3350 and Electrolytes | 21 | $298 | $14 |
| Pantoprazole | 12 | $121 | $10 |
2020: 2 drugs
| Pantoprazole | 44 | $769 | $17 |
| Omeprazole | 18 | $258 | $14 |
2019: 8 drugs
| Dexilant | 11 | $4,608 | $419 |
| Suprep | 45 | $4,388 | $98 |
| Ursodiol | 11 | $2,670 | $243 |
| Budesonide Ec | 14 | $1,934 | $138 |
| Moviprep | 18 | $1,880 | $104 |
| Pantoprazole | 32 | $583 | $18 |
| Omeprazole | 28 | $305 | $11 |
| Gavilyte-G | 15 | $242 | $16 |
2018: 3 drugs
| Suprep | 33 | $3,078 | $93 |
| Omeprazole | 19 | $306 | $16 |
| Pantoprazole | 13 | $97 | $7 |
2015: 1 drug
| Humira | 12 | $39,315 | $3,276 |
Money from drug and device companies
$155 in 2025
A payment is not proof that care is biased.
| Olympus America | Olympus | $122 | 1 payment
|
| Ipsen Biopharmaceuticals | Dysport | $33 | 1 payment
|
See all 2 published payments
| Olympus America | Meals · 2025-05-21 | Olympus | $122 |
| Ipsen Biopharmaceuticals | Meals · 2025-03-19 | Dysport | $33 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093031155
- Licence
- CA A119776California A119776: Current · expires 2027-08-31
- Trained
- New York Medical College, 2010
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-04-14
- NPI last updated
- 2017-12-27
This is when the NPI record was last certified, not a medical board exam.